Anabolic androgenic steroids induce micronuclei in bucca mucosa cells of bodybuilders

British Journal of Sports Medicine

Volumn 41, Issue 9, 2007, Pages 592-596

  Torres Bugarin O ^a   Covarrubias Bugarin R ^b   Zamora Perez, A L ^c   Torres Mendoza, B M G ^d   Garcia Ulloa M ^a   Martinez Sandoval F G ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^b Universidad del Valle de Atemajac   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

ADULT; ARTICLE; BODY BUILDING; CHEEK MUCOSA; CLINICAL ARTICLE; GENOTOXICITY; HUMAN; MALE; MICRONUCLEUS; RANK SUM TEST;

ADULT; ANABOLIC AGENTS; CASE-CONTROL STUDIES; HUMANS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MOUTH MUCOSA; WEIGHT LIFTING;

EID: 34548787730     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2006.032474     Document Type: Article

References (31)

1. Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics 2006;17:577-89.
2. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:513-54.
3. Bierly JR. Use of anabolic steroids by athletes. Do the risks outweigh the benefits? Postgrad Med 1987;82:67-8, 71-2, 74.
4. Kopera H. Anabolic steroids and sports. Win Med Wochenschr, 1986 30, 136:453-6.
5. Powers ME. The safety and efficacy of anabolic steroid precursors: what is the scientific evidence? J Athl Train 2002;37:300-5.
6. Clarkson PM, Rawson ES. Nutritional supplements to increase muscle mass. Crit Rev Food Sci Nutr 1999;4:317-28.
7. Bowers LD. Athletic drug testing. Clin Sports Med 1998;17:299-318.
8. Llewellyn W. Anabolics 2002. Anabolic steroid reference manual molecular nutrition. NewYork, 2002.
9. Schmid W. The micronucleus tests. Mutat Res 1975;31:9-15.
10. Heddle JA. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. environmental protection agency gene-tox program. Mutat Res 1983;123:61-118.
11. Heddle JA, Lue CB, Sounder F, et al. Sensitivity to five mutagens in Fanconis anemia as measured by the micronucleus method. Cancer Res 1978;38:2983-8.
12. Heddle JA, Cimino MC, Hayashi M, et al. Micronuclei as an index of cytogenetic damage: past, present, and future. Environ Mol Mutagen 1991;18:277-91.
13. Heddle JA. A rapid in vivo test for chromosomal damage. Mutat Res 1973;18:187-90.
14. Zúñiga-González G, Torres-Bugarín O, Luna-Aguirre J, et al. Spontaneous micronuclei in peripheral blood erythrocytes from 54 animal species (mammals, reptiles and birds): part two. Mutat Res 2000;467:99-103.
15. Zamora-Perez A, Zúñiga-González GM, Gómez-Meda BC, et al. Induction of micronucleated cells in the shed skin of salamanders (Ambystoma sp.) treated with colchicine or cyclophosphamide. Environ Mol Mutagen 2004;44:436-40.
16. Zúñiga-González G, Torres-Bugarín O, Zamora-Perez A, et al. Differences in the number of micronucleated erythrocytes among young and adult animals including humans. Spontaneous micronuclei in 43 species. Mutat Res 2001;494:161-7.
17. Zúñiga G, Torres-Bugarín O, Ramírez-Múñoz MP, et al. Micronucleated erythrocytes in splenectomized with and without chemotherapy. Mutat Res 1996;361:107-12.
18. Torres-Bugarín O, Zamora-Pérez A, Esparza-Flores A, et al. Eritrocitos micronucleados en niños esplenectomizados con y sin quimioterapia. Bol Méd Hos Infan Méx 1999;56:212-7.
19. Torres-Bugarín O, Ventura-Aguilar A, Zamora-Perez A, et al. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamida + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. Mutat Res 2003;539:177-86.
20. Torres-Bugarín O, De Anda-Casillas A, Ramírez- Múñoz MP, et al. Determination of diesel genotoxicity in firebreathers by micronuclei and nuclear abnormalities in buccal mucosa. Mutat Res 1998;30:277-81.
21. Ramos-Remus C, Dorazco-Barragan G, Aceves-Avila FJ, et al. Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients. Clin Exp Rheumatol 2002;20:208-12.
22. Reznikov AG, Sinitsyn PV. Role of testosterone metabolism in the hypothalamus in the regulation of the gonadotropic function of the hypophysis in pre- and postpuberal male rats. Probl Endokrinol (Mosk) 1990;36:68-71.
23. Joachim GL. Is estradiol a genotoxic mutagenic carcinogen? Endocrine Review 2005;21:40-54.
24. Hundal BS, Dhillon VS, Sidhu IS. Genotoxic potencial of estrogens. Mutat Res 1997;389:173-81.
25. Martelli A, Mattioli F, Angiola M, et al. Species, sex and inter-individual differences in DNA repair induced bye nine sex steroids in primary cultures of rat and human hepatocytes. Mutat Res 2003;536:69-78.
26. Hurh YJ, Chen ZH, Na HK, et al. 2-Hydroxyestradiol induces oxidative DNA damage and apoptosis in human mammary epithelial cells. J Toxicol Environ Health A 2004;67:1939-53.
27. Gracy RW, Talent JM, Kong Y, et al. Reactive oxygen species: the unavoidable environmental insult? Mutat Res 1999;428:17-22.
28. Schraufstatter IU, Hyslop PA, Hinshaw DB, et al. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 1986;83:4908- 12.
29. Hellman S, Vokes EE. Advancing current treatments for cancer. Sci Am 1996;275:84-9.
30. Djelic N, Spremo-Potparevic B, Djelic D. Mutagenic activity of estradiol evaluated by an in vitro micronucleus assay [short communication]. Acta Biol Hung 2005;56:403-6.
31. Fischer WH. Increased formations of micronuclei alter hormonal stimulation of cell proliferation in human breast cancer cells. Mutagenesis 2001;16:209-12.